Synthesis of a novel farnesyl transferase inhibitor, ABT-100; selective preparation of a stereogenic tertiary carbinol

A stereoselective synthesis of ABT-100 1 , a novel farnesyl transferase inhibitor, is described. The key step involves a stereoselective addition of the heterocyclic zinc reagent 10 to chiral α-keto ester 9 in >10:1 diastereoselectivity using menthol as the chiral auxiliary. Crystallization of th...

Full description

Saved in:
Bibliographic Details
Published inTetrahedron Vol. 61; no. 18; pp. 4419 - 4425
Main Authors Rozema, Michael J., Kruger, Albert W., Rohde, Bridget D., Shelat, Bhadra, Bhagavatula, Lakshmi, Tien, James J., Zhang, Weijiang, Henry, Rodger F.
Format Journal Article
LanguageEnglish
Published OXFORD Elsevier Ltd 02.05.2005
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A stereoselective synthesis of ABT-100 1 , a novel farnesyl transferase inhibitor, is described. The key step involves a stereoselective addition of the heterocyclic zinc reagent 10 to chiral α-keto ester 9 in >10:1 diastereoselectivity using menthol as the chiral auxiliary. Crystallization of the product as the dimeric zinc complex facilitates isolation of product in >99:1 dr. The biaryl linkage is formed by the use of a Suzuki coupling employing only 0.06 mol% of the catalyst. Coupling of the two fragments is accomplished using a S NAr reaction between diol 5 and arylfluoride 4 . The overall yield for the five step sequence is 37% on kilogram scale. The development of an asymmetric synthesis of farnesyl transferase inhibitor ABT-100 is presented. The preparation features the asymmetric addition of a heterocyclic organozinc reagent to set the tertiary carbinol and a regioselective S NAr reaction to prepare the phenolic ether linkage.
ISSN:0040-4020
1464-5416
DOI:10.1016/j.tet.2005.02.072